Summary
The product Oil sample TC AI, submitted for analysis by Mint Anabolics, underwent independent testing to verify its composition and potency. The sample was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The test confirmed the presence of Testosterone Cypionate at 274.60 mg/ml and Exemestane at 14.89 mg/ml.
The testing process began on 15 March 2024, with the sample received on 9 April 2024, and analysis completed on 11 April 2024. While the results confirm the product’s content, the lack of manufacturer and batch information raises concerns regarding product traceability and consistency. Independent third-party testing remains crucial for comprehensive validation. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Mint Anabolics
- Product Name: Oil sample TC AI
- Active Ingredients: Testosterone Cypionate, Exemestane
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Not specified
Sample Acquisition and Testing
- Task Number: #40764
- Testing Ordered: 15 March 2024
- Sample Received: 9 April 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Mint Anabolics (Manufacturer)
- Analysis Paid For By: Mint Anabolics (Manufacturer)
Testing Results
- Tested Compounds:
- Testosterone Cypionate: 274.60 mg/ml
- Exemestane: 14.89 mg/ml
Verification Details
Verification URL: https://janoshik.com/tests/40764_BDPXPWHVQSDL
Evaluation of Manufacturer-Submitted Testing
While this analysis confirms the presence and concentration of Testosterone Cypionate and Exemestane, the lack of manufacturer and batch information raises concerns about product traceability and consistency. The absence of these key details makes it difficult to assess quality control standards over time. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, independent validation through third-party testing remains essential.
Conclusion
The analysis confirms that the sample contains Testosterone Cypionate at 274.60 mg/ml and Exemestane at 14.89 mg/ml. However, without a specified manufacturer or batch number, further verification is necessary to ensure reliability and consistency across different samples. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic and aromatase inhibitor products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
